FDA Recalls BP Drug Valsartan For Cancer Concerns

The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

According to FDA, the recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. NDMA is classified as a probable human carcinogen—a substance that could cause cancer. The findings are based on results from recent laboratory test.

Not all products containing valsartan are being recalled.

The specific medicines recalled are:

  • Valsartan, Major Pharmaceuticals.
  • Valsartan, Solco Healthcare.
  • Valsartan, Teva Pharmaceuticals Industries Ltd.
  • Valsartan/Hydrochlorothiazide (HCTZ), Solco Healthcare.
  • Valsartan/Hydrochlorothiazide (HCTZ), Teva Pharmaceuticals Industries Ltd.

The FDA says that patients already taking the recalled medications should contact their pharmacist or doctor immediately.

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.